Literature DB >> 11813820

High-resolution CT of drug-induced lung disease.

Jeremy J Erasmus1, H Page McAdams, Santiago E Rossi.   

Abstract

Drug-induced pulmonary toxicity is increasing and early diagnosis is important because of the associated morbidity and mortality. Diagnosis is often difficult and is usually based on a history of drug therapy and exclusion of infection, radiation pneumonitis, and recurrence of the underlying disease. Although HRCT findings are frequently nonspecific, diagnosis can be facilitated by an understanding of the most common histopathologic and radiologic manifestations of drug-induced lung injury and knowledge of the drugs usually involved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11813820     DOI: 10.1016/s0033-8389(03)00109-x

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  11 in total

Review 1.  Pneumonia in neutropenic patients.

Authors:  C P Heussel; H-U Kauczor; A J Ullmann
Journal:  Eur Radiol       Date:  2003-07-24       Impact factor: 5.315

2.  Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab.

Authors:  Sree Harsha Tirumani; Nikhil H Ramaiya; Abhishek Keraliya; Nancy D Bailey; Patrick A Ott; F Stephen Hodi; Mizuki Nishino
Journal:  Cancer Immunol Res       Date:  2015-06-22       Impact factor: 11.151

3.  Drug-Related Pneumonitis During Mammalian Target of Rapamycin Inhibitor Therapy: Radiographic Pattern-Based Approach in Waldenström Macroglobulinemia as a Paradigm.

Authors:  Mizuki Nishino; Erica N Boswell; Hiroto Hatabu; Irene M Ghobrial; Nikhil H Ramaiya
Journal:  Oncologist       Date:  2015-07-23

Review 4.  Imaging of Cancer Immunotherapy: Current Approaches and Future Directions.

Authors:  Mizuki Nishino; Hiroto Hatabu; F Stephen Hodi
Journal:  Radiology       Date:  2018-11-20       Impact factor: 11.105

Review 5.  Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.

Authors:  Mizuki Nishino; Hiroto Hatabu; Lynette M Sholl; Nikhil H Ramaiya
Journal:  Radiographics       Date:  2017 Sep-Oct       Impact factor: 5.333

6.  Drug-related pneumonitis during mammalian target of rapamycin inhibitor therapy in patients with neuroendocrine tumors: a radiographic pattern-based approach.

Authors:  Mizuki Nishino; Lauren K Brais; Nichole V Brooks; Hiroto Hatabu; Matthew H Kulke; Nikhil H Ramaiya
Journal:  Eur J Cancer       Date:  2016-01-04       Impact factor: 9.162

7.  Drug induced interstitial lung disease.

Authors:  Martin Schwaiblmair; Werner Behr; Thomas Haeckel; Bruno Märkl; Wolfgang Foerg; Thomas Berghaus
Journal:  Open Respir Med J       Date:  2012-07-27

Review 8.  New targeted molecular therapies for cancer: radiological response in intrathoracic malignancies and cardiopulmonary toxicity: what the radiologist needs to know.

Authors:  Frederico F Souza; Andrew Smith; Cyrillo Araujo; Jyothi Jagannathan; Ciaran Johnston; Kevin O'Regan; Atul Shinagare; Nikhil Ramaiya
Journal:  Cancer Imaging       Date:  2014-07-23       Impact factor: 3.909

9.  Rapid onset of amiodarone induced pulmonary toxicity after lung lobe resection - A case report and review of recent literature.

Authors:  Heiko Baumann; Phillip Fichtenkamm; Thomas Schneider; Jürgen Biscoping; Michael Henrich
Journal:  Ann Med Surg (Lond)       Date:  2017-07-19

10.  Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms.

Authors:  Yuh-Min Chen; Reury-Perng Perng; Hsi Chu; Chun-Ming Tsai; Jacqueline Whang-Peng
Journal:  Lung Cancer       Date:  2004-07       Impact factor: 5.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.